{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:03Z","timestamp":1787020863190,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPVVN0221, CMRPVVN0231"],"award-info":[{"award-number":["CMRPVVN0221, CMRPVVN0231"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG5M0041, CMRPG3N0651, CORPG3P0301"],"award-info":[{"award-number":["CMRPG5M0041, CMRPG3N0651, CORPG3P0301"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG3P0591, CMRPG3L1152, CMRPG3L0872, CMRPG3N0671, CORPG3P0031"],"award-info":[{"award-number":["CMRPG3P0591, CMRPG3L1152, CMRPG3L0872, CMRPG3N0671, CORPG3P0031"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-182A-062-MY3"],"award-info":[{"award-number":["113-2314-B-182A-062-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-182-036-MY3"],"award-info":[{"award-number":["112-2314-B-182-036-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["111-2314-B-182A-018"],"award-info":[{"award-number":["111-2314-B-182A-018"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["CS-113-PP-14"],"award-info":[{"award-number":["CS-113-PP-14"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health Research Institutes and Central Government","award":["113-0324"],"award-info":[{"award-number":["113-0324"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peripheral artery disease (PAD) is a progressive vascular condition with high risks of limb amputation and adverse clinical outcomes. Despite advancements in revascularization techniques, risk stratification remains limited, especially in predicting long-term limb-specific complications. Epigenetic markers, such as DNA methylation, have emerged as potential tools for improving prognostication in vascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We prospectively enrolled 133 patients with symptomatic PAD confirmed by imaging and angiography, all of whom underwent endovascular or surgical revascularization. Peripheral blood samples were collected prior to intervention, and\n                      <jats:italic>VTRNA2-1<\/jats:italic>\n                      promoter methylation levels were quantified using bisulfite pyrosequencing. Hypomethylation was defined as methylation levels below 40%. Patients were followed for 12 months to monitor major adverse limb events (MALE), amputation, and renal outcomes. Methylation levels were compared to those of population-based controls from the Taiwan Biobank.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among enrolled patients, 42.9% exhibited\n                      <jats:italic>VTRNA2-1<\/jats:italic>\n                      hypomethylation. Hypomethylation was independently associated with increased amputation risk (odds ratio [OR] 2.19, 95% confidence interval [CI] 1.09\u20134.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035). In patients without end-stage renal disease (ESRD), hypomethylation was associated with higher rates of MALE (OR 2.78; 95% CI, 1.11\u20136.97;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028). Additionally, methylation levels in PAD patients were significantly lower than those in population-based controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>VTRNA2-1<\/jats:italic>\n                      hypomethylation is associated with increased risk of limb-related complications in PAD patients, especially among those without ESRD. These findings suggest that\n                      <jats:italic>VTRNA2-1<\/jats:italic>\n                      methylation status may serve as a promising biomarker for refining risk stratification in PAD. Further validation in external cohorts and mechanistic studies are warranted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02087-z","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:22:39Z","timestamp":1772191359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Ming-Lung","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih-Kai","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Yuan","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Neu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"2087_CR1","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song P, et al. Global, regional, and National prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020\u201330. https:\/\/doi.org\/10.1016\/S2214-109X(19)30255-4.","journal-title":"Lancet Glob Health"},{"key":"2087_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/(SICI)1096-9136(199603)13:3<243::AID-DIA69>3.0.CO;2-U","volume":"13","author":"NL Katsilambros","year":"1996","unstructured":"Katsilambros NL, et al. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabet Med. 1996;13:243\u20136. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199603)13:3%3C243::AID-DIA69%3E3.0.CO;2-U.","journal-title":"Diabet Med"},{"key":"2087_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jacc.2006.05.049","volume":"48","author":"MA Allison","year":"2006","unstructured":"Allison MA, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic study of atherosclerosis (MESA). J Am Coll Cardiol. 2006;48:1190\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2006.05.049.","journal-title":"J Am Coll Cardiol"},{"key":"2087_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","volume":"116","author":"MH Criqui","year":"2015","unstructured":"Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509\u201326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303849.","journal-title":"Circ Res"},{"key":"2087_CR5","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1038\/ncomms4746","volume":"5","author":"P Dominguez-Salas","year":"2014","unstructured":"Dominguez-Salas P, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014;5:3746. https:\/\/doi.org\/10.1038\/ncomms4746.","journal-title":"Nat Commun"},{"key":"2087_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13059-015-0660-y","volume":"16","author":"MJ Silver","year":"2015","unstructured":"Silver MJ, et al. Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment. Genome Biol. 2015;16:118. https:\/\/doi.org\/10.1186\/s13059-015-0660-y.","journal-title":"Genome Biol"},{"key":"2087_CR7","doi-asserted-by":"publisher","first-page":"e011768","DOI":"10.1136\/bmjopen-2016-011768","volume":"6","author":"S Finer","year":"2016","unstructured":"Finer S, et al. Is famine exposure during developmental life in rural Bangladesh associated with a metabolic and epigenetic signature in young adulthood? A historical cohort study. BMJ Open. 2016;6:e011768. https:\/\/doi.org\/10.1136\/bmjopen-2016-011768.","journal-title":"BMJ Open"},{"key":"2087_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13148-021-01132-3","volume":"13","author":"S Marttila","year":"2021","unstructured":"Marttila S, et al. Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs. Clin Epigenetics. 2021;13:143. https:\/\/doi.org\/10.1186\/s13148-021-01132-3.","journal-title":"Clin Epigenetics"},{"key":"2087_CR9","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"C Ling","year":"2019","unstructured":"Ling C, Ronn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29:1028\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2019.03.009.","journal-title":"Cell Metab"},{"key":"2087_CR10","doi-asserted-by":"publisher","unstructured":"Shen B et al. Association of Race and Poverty Status With DNA Methylation-Based Age. JAMA Netw Open 6, e236340 (2023). https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.6340","DOI":"10.1001\/jamanetworkopen.2023.6340"},{"key":"2087_CR11","doi-asserted-by":"publisher","first-page":"E11970","DOI":"10.1073\/pnas.1815005115","volume":"115","author":"BL Carpenter","year":"2018","unstructured":"Carpenter BL, et al. Mother-child transmission of epigenetic information by tunable polymorphic imprinting. Proc Natl Acad Sci U S A. 2018;115:E11970\u20137. https:\/\/doi.org\/10.1073\/pnas.1815005115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2087_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ijo.2017.228","volume":"42","author":"SJ van Dijk","year":"2018","unstructured":"van Dijk SJ, et al. DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood. Int J Obes (Lond). 2018;42:28\u201335. https:\/\/doi.org\/10.1038\/ijo.2017.228.","journal-title":"Int J Obes (Lond)"},{"key":"2087_CR13","doi-asserted-by":"publisher","unstructured":"Kim Y, et al. nc886, a Non-Coding RNA, is a new biomarker and epigenetic mediator of cellular senescence in fibroblasts. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222413673.","DOI":"10.3390\/ijms222413673"},{"key":"2087_CR14","doi-asserted-by":"publisher","unstructured":"Lin CH, Lee YS, Huang YY, Tsai CN. Methylation status of vault RNA 2\u2009\u2013\u20091 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2021;9. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001416.","DOI":"10.1136\/bmjdrc-2020-001416"},{"key":"2087_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11033-024-09305-y","volume":"51","author":"RG Avila-Bonilla","year":"2024","unstructured":"Avila-Bonilla RG, Mart\u00ednez-Montero JP. Crosstalk between vault RNAs and innate immunity. Mol Biol Rep. 2024;51:387.","journal-title":"Mol Biol Rep"},{"key":"2087_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1176\/appi.ajp.2016.16020138","volume":"174","author":"KJ O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell KJ, Meaney MJ. Fetal origins of mental health: the developmental origins of health and disease hypothesis. Am J Psychiatry. 2017;174:319\u201328. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16020138.","journal-title":"Am J Psychiatry"},{"key":"2087_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1375\/twin.10.6.848","volume":"10","author":"S Zdravkovic","year":"2007","unstructured":"Zdravkovic S, Wienke A, Pedersen NL, de Faire U. Genetic susceptibility of myocardial infarction. Twin Res Hum Genet. 2007;10:848\u201352. https:\/\/doi.org\/10.1375\/twin.10.6.848.","journal-title":"Twin Res Hum Genet"},{"key":"2087_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/gb-2012-13-10-172","volume":"13","author":"JT Bell","year":"2012","unstructured":"Bell JT, Spector TD. DNA methylation studies using twins: what are they telling us? Genome Biol. 2012;13:172. https:\/\/doi.org\/10.1186\/gb-2012-13-10-172.","journal-title":"Genome Biol"},{"key":"2087_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","volume":"2","author":"PP Rickham","year":"1964","unstructured":"Rickham PP, Human Experimentation, Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J. 1964;2:177. https:\/\/doi.org\/10.1136\/bmj.2.5402.177.","journal-title":"Br Med J"},{"key":"2087_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCRESAHA.115.305206","volume":"118","author":"J Zhong","year":"2016","unstructured":"Zhong J, Agha G, Baccarelli AA. The role of DNA methylation in cardiovascular risk and disease: methodological Aspects, study Design, and data analysis for epidemiological studies. Circ Res. 2016;118:119\u201331. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.305206.","journal-title":"Circ Res"},{"key":"2087_CR21","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1158\/0008-5472.CAN-12-3055","volume":"73","author":"J Cao","year":"2013","unstructured":"Cao J, et al. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res. 2013;73:3326\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3055.","journal-title":"Cancer Res"},{"key":"2087_CR22","doi-asserted-by":"publisher","unstructured":"Lee YS, Lee YS. nc886, an RNA polymerase III-Transcribed noncoding RNA whose expression is dynamic and regulated by intriguing mechanisms. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24108533.","DOI":"10.3390\/ijms24108533"},{"key":"2087_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s41467-018-03556-7","volume":"9","author":"JH Ahn","year":"2018","unstructured":"Ahn JH, et al. nc886 is induced by TGF-beta and suppresses the MicroRNA pathway in ovarian cancer. Nat Commun. 2018;9:1166. https:\/\/doi.org\/10.1038\/s41467-018-03556-7.","journal-title":"Nat Commun"},{"key":"2087_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13148-025-01871-7","volume":"17","author":"S Rajic","year":"2025","unstructured":"Rajic S, et al. Regulation of nc886 (vtRNA2-1) RNAs is associated with cardiometabolic risk factors and diseases. Clin Epigenetics. 2025;17:68. https:\/\/doi.org\/10.1186\/s13148-025-01871-7.","journal-title":"Clin Epigenetics"},{"key":"2087_CR25","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","volume":"65","author":"JA Chan","year":"2005","unstructured":"Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0137.","journal-title":"Cancer Res"},{"key":"2087_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang S, et al. The endothelial-specific MicroRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261\u201371. https:\/\/doi.org\/10.1016\/j.devcel.2008.07.002.","journal-title":"Dev Cell"},{"key":"2087_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.3487","volume":"20","author":"A Schober","year":"2014","unstructured":"Schober A, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20:368\u201376. https:\/\/doi.org\/10.1038\/nm.3487.","journal-title":"Nat Med"},{"key":"2087_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes KR, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460:705\u201310. https:\/\/doi.org\/10.1038\/nature08195.","journal-title":"Nature"},{"key":"2087_CR29","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/cdd.2009.153","volume":"16","author":"L Elia","year":"2009","unstructured":"Elia L, et al. The knockout of miR-143 and \u2013\u2009145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009;16:1590\u20138. https:\/\/doi.org\/10.1038\/cdd.2009.153.","journal-title":"Cell Death Differ"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02087-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:01:30Z","timestamp":1775221290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02087-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02087-z","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of CGMH approved the study protocol (IRB No. 202000472A3; 202201980A3C501; 202301387A3; 202301900B0; 202300971A3). All participants provided written informed consent. This study was conducted in accordance with the tenets of the Declaration of Helsinki and the ethical regulations of the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}